Seeking Alpha

Dendreon (DNDN)

()

Comments on DNDN

  • Speculative BioTechs: Finding the Next 10-Bagger [View instapost]
    I guess the recent run in $SNSS will improve this result. $SNSS $0.21 $2.10 1000%
    Comment by Goosie69
    Dec 11 11:31 am |
    Rating: 0 0
  • Ten Stock Picks for 2009 [View article]
    Obama is sinking faster than the titanic ...jump offf jump now!!! On Jan 05 09:56 AM deee wrote: > Well you can buy this junk,... More »
    Comment by BAKERBOY
    Nov 23 21:35 pm |
    Rating: 0 0
  • 12 Stem Cell Stocks - Updated [View article]
    this list here is the exact list at http://stemcellstocks.info
    Comment by jenny besworth
    Nov 20 15:42 pm |
    Rating: 0 0
  • 30 High Yielding Option Write Ideas for November Option Expiration Friday [View article]
    Marco~ Are commissions and bid-asked spread included in your calculations? George
    Comment by George Spritzer
    Nov 20 08:51 am |
    Rating: +1 0
  • 25 Option Write Ideas for October's Expiration Friday [View article]
    i just don't have the perfect word right now but you are really outstanding ,your experience and your vision is also marvelous.i will... More »
    Comment by little star
    Nov 20 05:02 am |
    Rating: +1 0
  • Dendreon's Provenge Looks Likely to Be Approved in Mid-2010 [View article]
    It is amazing that a failed gradient separation technology can be used to produce a dendritic cell vaccine that has efficacy. Look at... More »
    Comment by Blurtman
    Nov 16 17:02 pm |
    Rating: 0 0
  • Dendreon's Provenge Looks Likely to Be Approved in Mid-2010 [View article]
    Nice article. Let me add something. Dendreon filed the amended Biologics License Application (aBLA) with the FDA on October 30th.... More »
    Comment by inhumane fda
    Nov 11 11:34 am |
    Rating: +1 0
  • Cramer's Mad Money - Hey Big Spenders (11/5/09) [View article]
    KFT is at a good entry point if you want to buy it now. Compared to K and GIS, my 2 cents is that KFT is not the best company of this... More »
    Comment by Dotcom
    Nov 6 12:50 pm |
    Rating: 0 0
  • Cramer's Mad Money - Hey Big Spenders (11/5/09) [View article]
    Mr. Cramer, If Kraft is good enough for Warren Buffett, who has expressed confidence in the CEO, then its good enough for me. By the... More »
    Comment by EJC1645
    Nov 6 10:51 am |
    Rating: +2 0
  • Dendreon's Provenge Looks Likely to Be Approved in Mid-2010 [View article]
    This article is right on target. The only exception I would take is the anticipated approval date. Since this drug will no doubt... More »
    Comment by Willard Cantrel
    Nov 4 17:58 pm |
    Rating: +1 0
  • Dendreon's Provenge Looks Likely to Be Approved in Mid-2010 [View article]
    Its amazing that people have short memory! Previously, DNDN wanted to get approval based on small phase II trials with PFS as an... More »
    Comment by Reg Expert
    Nov 3 21:39 pm |
    Rating: +1 -3
  • Dendreon's Provenge Looks Likely to Be Approved in Mid-2010 [View article]
    Very interesting...I have been following for quite some time and contend that had this immunotherapy been for AIDS or Breast... More »
    Comment by Teddie01
    Nov 3 16:03 pm |
    Rating: +1 0
  • Dendreon's Provenge Looks Likely to Be Approved in Mid-2010 [View article]
    Man, what an utterly clueless comment. What subset are you talking about? The previous pivotal trial was p=0.01 for survival over the... More »
    Comment by Wall Diver
    Nov 3 12:04 pm |
    Rating: +1 -1
  • Dendreon's Provenge Looks Likely to Be Approved in Mid-2010 [View article]
    Approval looks extremely likely. Not sure why they didn't request Fast Track given the importance and that this is the second go round.
    Comment by PaperGains
    Nov 3 11:35 am |
    Rating: 0 0
  • Dendreon's Provenge Looks Likely to Be Approved in Mid-2010 [View article]
    FDA will approve as long as the company is honest and shows integrity in its analysis of data that forms the core part of its BLA.... More »
    Comment by Reg Expert
    Nov 3 09:53 am |
    Rating: +1 -7